...
首页> 外文期刊>Journal of chemotherapy >Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring
【24h】

Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring

机译:Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring

获取原文
获取原文并翻译 | 示例
           

摘要

Vancomycin is frequently used in haemodialysis (HD) patients but generally accepted target serum ranges and dosing strategy are still lacking in this group. Based on retrospective analysis of data from 118 HD patients treated with vancomycin the interdialytic elimination constant (K-e), apparent volume of distribution (Vd) and dialysis efficacy were calculated. The influence of possible clinical variables on the pharmacokinetic parameters of vancomycin have been tested. The median of K-e in interdialytic periods, corresponding half-life and Vd were 0.0073 h(-1), 95.0 h and 0.87 L/kg, respectively. We found significant positive correlation between time in dialysis program and K-e. The Vd correlated best with lean body mass (LBM). For high- and low flux membrane HD of 4 hours duration the decline in vancomycin levels was 20.88% and 12.86%, respectively. Based on these data loading dose for vancomycin in HD patient should be calculated as 24.483 x LBM (kg) + 455 mg. The utility of this equation for entire HD population should be also verified prospectively.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号